OVERCOMING CANCER RESISTANCE BY HACKING CELL COMMUNICATION
CONTROLLING CANCER CELL COMMUNICATION
OncoXome is a biotech company focusing on the interference and manipulation of cancer cell communication. Through the combination of gene therapy and its optimal delivery system, OncoXome develops a new therapeutic approach.
The objective of its 2 combined platforms is to hack cancer cell communication to induce cancer cell apoptosis and inhibit cancer progression and resistance.
REVOLUTIONIZING THE CONCEPT OF CANCER
OncoXome defines cancer as a complex ecosystem in which cells communicate, interact, support each other, exchange information, messages of alert and resistance capabilities. Because of this elaborate communication network, cancer cells adapt to new conditions and aggressions, acquiring resistance to treatments. Cancer cells also communicate with their environment, such as immune and stromal cells to manipulate them, making the tumor environment tolerant and even cooperative.
LIMITED EFFICACY
